Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience

NCT07231796 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Opioid Induced Constipation (OIC)

Interventions

DRUG: Naldemedine, an peripherally acting opioid antagonist

Sponsor

Professor Monique A. H. Steegers

Collaborators

[object Object]